MiMedx Group (MDXG) Earnings Date, Estimates & Call Transcripts $7.26 -0.05 (-0.68%) As of 01:32 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock MiMedx Group Earnings Summary MiMedx Group posted Q2 2025 earnings on July 30, 2025, reporting an EPS of $0.10, which topped the consensus estimate of $0.06 by $0.04. Quarterly revenue was reported to be $98.61 million, above analysts' expectations of $90.79 million. With a trailing EPS of $0.21 and a P/E Ratio of 34.64, MiMedx Group's earnings are expected to grow 6.67% next year, from $0.30 to $0.32 per share. Upcoming Q3 Earnings DateOct. 29After Market ClosesEstimatedConsensus EPS (Jul. 30) $0.06 Actual EPS (Jul. 30) $0.10 Beat By $0.04 Actual Revenue (Jul. 30) $98.61MQ2 2025 Earnings ResourcesQ2 2025 Earnings ReportConference Call Transcript & Audio Quarterly Report (10-Q) Press Release (8-K)MDXG Upcoming EarningsMiMedx Group's Q3 2025 earnings is scheduled for Wednesday, October 29, 2025, with a conference call scheduled at 4:30 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Q3 2025 Earnings ReportPowered by Get MiMedx Group Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on MiMedx Group and other key companies, straight to your inbox. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Estimated and Actual Earnings DataMDXG Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.MDXG Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. MiMedx Group Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251$0.06$0.06$0.06Q2 20251$0.06$0.06$0.06Q3 20251$0.07$0.07$0.07Q4 20251$0.08$0.08$0.08 MiMedx Group Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 10/29/2025(Estimated)-------7/30/2025Q2 2025$0.06$0.10+$0.04$0.06$90.79M$98.61M4/30/2025Q1 2025$0.06$0.06-$0.05$86.32M$88.21M2/26/2025Q4 2024$0.07$0.07-$0.05$89.42M$92.91M10/30/2024Q3 2024$0.05$0.07+$0.02$0.09$81.00M$84.06M7/31/2024Q2 2024$0.08$0.08-$0.04$88.44M$87.21M4/30/2024Q1 2024$0.04$0.07+$0.03$0.08$79.36M$84.71M2/28/2024Q4 2023$0.08$0.04 -$0.04-$0.24$85.58M$86.83M10/30/2023Q3 2023$0.04$0.05+$0.01$0.04$76.69M$81.71M MiMedx Group Earnings - Frequently Asked Questions When is MiMedx Group's earnings date? MiMedx Group has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, October 29th, 2025 based off last year's report dates. Learn more on MDXG's earnings history. Did MiMedx Group beat their earnings estimates last quarter? In the previous quarter, MiMedx Group (NASDAQ:MDXG) reported $0.10 earnings per share (EPS) to beat the analysts' consensus estimate of $0.06 by $0.04. Learn more on analysts' earnings estimate vs. MDXG's actual earnings. How can I listen to MiMedx Group's earnings conference call? The conference call for MiMedx Group's latest earnings report can be listened to online. Listen to Conference Call How can I read MiMedx Group's conference call transcript? The conference call transcript for MiMedx Group's latest earnings report can be read online. Read Transcript How much revenue does MiMedx Group generate each year? MiMedx Group (NASDAQ:MDXG) has a recorded annual revenue of $348.88 million. How much profit does MiMedx Group generate each year? MiMedx Group (NASDAQ:MDXG) has a recorded net income of $42.42 million. MDXG has generated $0.21 earnings per share over the last four quarters. What is MiMedx Group's price-to-earnings ratio? MiMedx Group (NASDAQ:MDXG) has a trailing price-to-earnings ratio of 34.67 and a forward price-to-earnings ratio of 24.20. What is MiMedx Group's EPS forecast for next year? MiMedx Group's earnings are expected to grow from $0.30 per share to $0.32 per share in the next year, which is a 6.67% increase. More Earnings Resources from MarketBeat Related Companies TransMedics Group Earnings Date Soleno Therapeutics Earnings Date Envista Earnings Date LivaNova Earnings Date Inspire Medical Systems Earnings Date National Vision Earnings Date PROCEPT BioRobotics Earnings Date Artivion Earnings Date LeMaitre Vascular Earnings Date Liquidia Technologies Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Tesla Earnings Loom: Bulls Eye $600, Bears Warn of $300Spotify Could Surge Higher—Here’s the Hidden Earnings SignalBerkshire-Backed Lennar Slides After Weak Q3 EarningsWall Street Eyes +30% Upside in Synopsys After Huge Earnings FallRH Stock Slides After Mixed Earnings and Tariff ConcernsCelsius Stock Surges After Blowout Earnings and Pepsi DealWhy DocuSign Could Be a SaaS Value Play After Q2 Earnings This page (NASDAQ:MDXG) was last updated on 10/7/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredU.S. Government Sparking Crypto RallyU.S. Puts GDP on the Blockchain Could this spark the next crypto supercycle? Discover the altcoins poised t...Crypto 101 Media | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MiMedx Group, Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share MiMedx Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
